Evaluation of effectiveness and tolerance of treatment with Azithromycin 1.5% eye drops in bacterial conjunctivitis;Ocena skuteczności i tolerancji 1,5% kropli ocznych azytromycyny w leczeniu bakteryjnego zapalenia spojówek

Klinika Oczna

Volumn 111, Issue 1-3, 2009, Pages 46-49

  Ambroziak, Anna M ^a   Szaflik, Jacek P ^a   Hapunik, Adam ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Azyter; Macrolide; Purulent bacterial conjunctivitis; Topical azithromycin 1.5 eyedrops

Indexed keywords

AZITHROMYCIN; EYE DROPS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AZITHROMYCIN; CONJUNCTIVITIS, BACTERIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67651160526     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R: Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987, 31, 1939-1947. (Pubitemid 18009566)
2. Peters DH, Friedel HA, McTavish D: Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992, 44(5), 750-799.
3. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T et al.: Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrobial Agents and Chemotherapy 1996, 40(3), 825-826. (Pubitemid 26071561)
4. Triglycerides - Medium Chain. In "European Pharmacopeia 6.0. 2008", 3122-3124.
5. Drew RH, Gallis HA: Azithromycin - Spectrum of Activity, Pharmacokinetics, and Clinical Applications. Pharmacotherapy 1992, 12(3), 161-173.
6. Amar T, Caillaud T, Elena P: Ocular Pharmacokinetic Study Following Single and Multiple Azithromycin Administrations in Pigmented Rabbits. Current Eye Research 2008, 33, 149-158. (Pubitemid 351302201)
7. Van Bambeke F, Tulkens PM: Macrolides: pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2001, 18 Suppl 1, 17-23.
8. Luchs J: Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Advances in Therapy 2008 Sep, 25(9), 858-870.
9. Denis F, Chaumeil C, Goldschmidt P, Delval L, Pouliquen P, Cochereau I, Chainier D, De Barbeyrac B: Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. Eur J Ophthalmol. 2008 Nov-Dec, 18(6), 858-868.
10. Soukiasian SH, Baum J: Bacterial conjunctivitis. 2nd Edition. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea 2005, Philadelphie, USA: Elsevier Mosby.
11. Sheikh A, Hurwitz B, Cave J: Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2000, CD001211.
12. Sheikh A: Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2006, CD001211.
13. Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract. 2001;51:473-477. (Pubitemid 32509650)